Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Sarcoma 2Multiple Myeloma 2Lung Neoplasms 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Fatigue 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Weight Loss 1Uterine Cervical Neoplasms 1Thrombocytopenia 1Symptom Management 1Stomach Neoplasms 1Splenomegaly 1Sexual Dysfunction, Physiological 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Synovial 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Temozolomide 156Bevacizumab 69Radiotherapy 61Magnetic Resonance Spectroscopy 59Irinotecan 31Surgical Procedures, Operative 23Radiation 23Carboplatin 23Specimen Handling 20Carmustine 20Nivolumab 19Biopsy 17Lomustine 15Aminolevulinic Acid 15Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12pembrolizumab 12Radiosurgery 12Erlotinib Hydrochloride 12fluorodopa F 18 11Topotecan 11Everolimus 11Blood Specimen Collection 11X-Rays 10IL13-PE38 10dabrafenib 9Etoposide 9ribociclib 8poly ICLC 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Glioma × Quality of Life × Clear all
NCT03257618 2026-03-12

TEMOIN

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
26 enrolled
CNS

Glioma

NCT00667394 2015-11-05

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled 11 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡